Recent progress in nanotechnology for cancer therapy.

Area of Science:

• Oncology
• Nanomedicine
• Biotechnology

Background:

• Nanotechnology offers significant advancements in cancer diagnosis, treatment, and management.
• Targeted delivery of drugs, genes, and proteins to tumor tissues is a key promise of nanomedicine, aiming to reduce systemic toxicity.
• Current nanotechnologies are being developed to overcome challenges in cancer therapy.

Purpose of the Study:

• To review current nanotechnology platforms for anticancer drug delivery.
• To discuss nanotechnologies for combination therapeutic strategies in cancer treatment.
• To raise awareness of the advantages and challenges of applying therapeutic nanotechnologies in oncology.

Main Methods:

• Review of existing literature on nanotechnology platforms for cancer drug delivery.
• Analysis of various nanoparticle types: polymeric nanoparticles, liposomes, dendrimers, nanoshells, carbon nanotubes, superparamagnetic nanoparticles, and nucleic acid-based nanoparticles (DNA, RNA interference (RNAi), and antisense oligonucleotide (ASO)).
• Examination of combination therapeutic strategies involving nanotechnologies with multidrug-resistance modulators, ultrasound, hyperthermia, or photodynamic therapy.

Main Results:

• Several nanotechnology platforms show promise for targeted anticancer drug delivery.
• Combination strategies integrating nanotechnologies with other therapies offer potential for enhanced treatment efficacy.
• Recent advances highlight both the benefits and challenges associated with these nanotechnologies in clinical practice.

Conclusions:

• Nanotechnology platforms provide diverse strategies for targeted cancer drug delivery, improving therapeutic outcomes.
• Combining nanotechnologies with other modalities presents a promising avenue for overcoming cancer treatment limitations.
• Further research is needed to address the challenges and fully realize the potential of nanomedicine in cancer therapy.